𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Heterogeneous Distribution of Tumor Blood Supply Affects the Response to Chemotherapy in Patients with Head and Neck Cancer

✍ Scribed by FELIPE C. GALMARINI; CARLOS M. GALMARINI; MARÍA I. SARCHI; JORGE ABULAFIA; DARÍO GALMARINI

Book ID
109243637
Publisher
Informa plc
Year
2000
Tongue
English
Weight
766 KB
Volume
7
Category
Article
ISSN
1073-9688

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors that affect response to chemothe
Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer
✍ Magid H. Amer; Muhyi Al-Sarraf; Vainutis K. Vaitkevicius 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

A review of 164 patients with far advanced head and neck cancer, treated by a cytotoxic chemotherapy over a ten year period, at WAyne State University, Detroit, Michigan, was done in an attempt to determine factors that may influence the response to chemotherapy and subsequent survival. Response rat

Predictive factors for tumor response to
Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma: The head and neck contracts program
✍ Gregory T. Wolf; Robert W. Makuch; Shan R. Baker 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

The high tumor response rates associated with intensive chemotherapy in previously untreated patients with advanced head and neck squamous cell carcinoma (HNSCC) led to the initiation of a multi-institutional National Cancer Institute trial. This trial used preoperative chemotherapy in patients with

The correlation of specific variables of
The correlation of specific variables of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction chemotherapy
✍ John F. Ensley; Julie A. Kish; Arthur A. Weaver; John R. Jacobs; Mohammad Hassan 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

The authors have reported previously that conventionally defined grades of tumor morphology do not correlate with tumor response or survival in advanced squamous cell cancers of the head and neck (SCCHN) treated with cisplatinum combination induction therapy. This lack of correlation may be the resu